First Skin Cancer Patients Treated With Electronic Brachytherapy (eBx) At University of Wisconsin Riverview Cancer Center
... on three patients with non-melanoma skin cancers
under the direction of James S. Welsh, M.S., ... FDA cleared for use in the treatment of surface cancers
or conditions where radiation therapy is ... is also cleared for use in the treatment of other cancers
or conditions where radiation therapy is ...
Why Do African-Americans Fare Worse With Cancer? Access and Economics Are Only Part of the Story
... in survival based on race for a number of other cancers
-- lung, colon, lymphoma, leukemia, and multiple ... African-American patients with one of these three cancers
faced a significantly higher risk of death than ... the metabolism of chemotherapy drugs or that make cancers
more resistant or more aggressive," she adds.
Data From Clinical Study of bioTheranostics Molecular Diagnostic Test Presented at American Society of Clinical Oncology Annual Meeting
... the inability to diagnose patients' primary cancers
makes it more difficult for physicians to ... tests, thereby helping to reduce the number of cancers
that remain "unknown".
The blinded study ... methods often fail to properly diagnose unknown cancers
even after extensive work-up that could cost up ...
Investigational Genetic Test May Help Address Common Problems in Prostate Cancer Diagnosis
... as accurately identifying potentially aggressive cancers
while minimizing "false positive" results that ... need better tools to detect significant prostate cancers
earlier, to reduce unnecessary biopsies and ... higher in men with pathologically significant cancers
than in men with insignificant ones.(2)
Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update
... of Clinical Oncology (ASCO) 2009 Genitourinary cancers
Symposium. Efficacy results to date showed ... cancer (CRC) at the ASCO 2009 Gastrointestinal cancers
Symposium. Results continued to show that ... 2 trials of picoplatin in colorectal and prostate cancers
at medical conferences this year; and
Ascenta Therapeutics Announces Positive Preliminary Results with AT-101 in Docetaxel Refractory Prostate Cancer
... Society of Clinical Oncology (ASCO) Genitourinary cancers
MALVERN, Pa., Feb. 27 ... Society of Clinical Oncology (ASCO) Genitourinary cancers
Symposium in Orlando, FL. AT-101, an oral, ... treatment. One process by which prostate cancers
may develop resistance to systemic treatment is ...
Algeta Completes Comprehensive Phase II Clinical Program With Alpharadin for Treating Bone Metastases in Patients With Advanced Prostate Cancer
... arise from a number of high incidence cancers
as well as HRPC
(e.g. breast, lung and thyroid). ... are a serious consequence of
certain advanced cancers
causing intractable and debilitating pain as well ... in patients with lung, kidney and
- respectively in 30-40%, 20-25% and 60% of ...
New Breast Imaging Technology Targets Hard-to-Detect Cancers
(BSGI) is effective in the detection of cancers
not found on mammograms or by
clinical exam, ... and clinical
breast exam. However, some cancers
are difficult to detect with mammography
and ... excellent tool for locating
and for screening high-risk women who have ...
Young Women Diagnosed with Early-Stage Breast Cancer More Likely to Die than Older Women
... They looked at all young women
with Stage I cancers
and compared them with older women with Stage ... women under 40 diagnosed with Stages I
and II cancers
are 44 percent and 9 percent, respectively, more ... is found in all
the cells of the human body. Some cancers
make extra copies of this gene,
which also is ...
National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon
... cause of cancer death in the
U.S. However, most cancers
of the lower gastrointestinal (GI) tract can ... that
12-24% of polyps and a significant number of cancers
can be missed during
colonoscopy. , , 
... for the improved detection
and prevention of cancers
of the gastrointestinal (GI) tract.
AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108
... is part of a Phase 2 program
in gynaecological cancers
for which patient enrolment began in ... Phase 1 study in various gynaecological cancers
presented at the American Society of ... with LHRH-receptor positive
were recruited. AEZS-108 was administered ...
ASGE Encourages Patients to Speak to Their Doctor About Colorectal Cancer Screening Options
most likely to become cancerous) or cancers
10 mm or larger that were
detected by colonoscopy ... The sensitivity for the detection of adenomas or cancers
greater than or equal to 5 mm, 6 mm, 7 mm, 8 ... detection by CT colonography of
large adenomas or cancers
10 mm or larger. The radiologists making ...
Prescription Sleeping Pill Use Tied to Cancer
... Kripke found eight non-melanoma skin cancers
and four tumors
of uncertain malignancy in the ... to have
developed kidney, thyroid and testicular cancers
and suffer chromosome
damage, which is a sign of ... studies of several drugs and the
number of cancers
observed during controlled hypnotics trials ...
Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
... potential treatment for specific types of brain cancers
activity against human pancreatic cancers
in a mouse model.
Dr. John S. Kovach, President ... activity against several
types of human cancers
in the test tube and against ...
Task Force Says Men Age 75 and Older Should Not Be Screened For Prostate Cancer
... than the digital rectal exam. However, prostate cancers
found with a PSA test take years to ... incontinence and impotence. These
may never have affected a patient's health ... detected by screening.
"Because many prostate cancers
grow slowly, early detection may not
benefit a ...
Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K/mTOR Inhibitor XL765 at ASCO
... preclinical models.
Five patients with various cancers
have experienced stable disease for
at least ... development of treatments for the many different cancers
the PI3K pathway," said Dr. ... cell growth. PI3K is activated in human cancers
by elevated receptor
tyrosine kinase activity, by ...
Annual FIT Testing Detects Colorectal Cancer Two Years Earlier Than Colonoscopy Alone, Study of High-Risk Population Finds
... (n=14) and the non-FIT cohort
(n=14), colorectal cancers
in the FIT cohort were detected an average ... detected 86 percent (12 of 14) of colorectal cancers
percent (60 of 96) of advanced adenomas ... Currently, less than 40
percent of colorectal cancers
are found early.(3) The new data presented
Adding Breast Ultrasound Screening to Mammography Reveals Cancers not Seen on Mammography Alone in Women at Increased Risk for Breast Cancer
routine mammography revealed 28 percent more cancers
alone. However, the additional ... screening. Mammography alone revealed 20 cancers
(50 percent of all
cancers detected) for a cancer ... mammography
plus screening ultrasound revealed 31 cancers
(78 percent of all cancers
detected) for a cancer ...
Genomic Health Announces Identification of Genes Associated With Colon Cancer Recurrence Across Multiple Studies
... Society of Clinical Oncology
Symposium to be Used in Selecting Final Genes for ... Society of Clinical Oncology's Gastrointestinal cancers
in Orlando, Florida.
"These results ... chemotherapy.
The first report evaluated colon cancers
from patients treated with
surgery alone, ...
Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium
... in Gastroesophageal and Colorectal cancers
NUTLEY, N.J., Jan. 24 /PRNewswire/ -- Roche ... for presentation at the 2008 Gastrointestinal cancers
Orlando, Fla., from Jan. 25 to 27.
... to 5-FU in
gastroesophageal and colorectal cancers
and support further clinical
testing to examine ...
Cleveland Clinic Leading Clinical Program to Improve Early-Stage Lung Cancer Detection
... States annually than
breast, prostate and colon cancers
combined.(1) Eighty million chest X-rays
are ... However, without chest X-ray CAD, many lung cancers
be found or are overlooked when lung ... on the market.(3)
"Unfortunately, most lung cancers
are diagnosed too late for treatment
BiPar Begins Phase 2 Study of Lead PARP Inhibitor in Triple-Negative Breast Cancer Based on Overexpression Biomarker Data
... are associated with
a high rate of relapse. Such cancers
are particularly prevalent in
premenopausal ... gene expression in 169 infiltrating ductal breast cancers
use of the Gene Logic Inc. (Nasdaq: ... and Phase 2 trials of BSI-201 in other
that overexpress PARP over the next several ...
Jennerex Presents Clinical Data From JX-594 Demonstrating Tumor Efficacy Against Advanced Liver Cancers
... in primary liver
(HCC) cancers, squamous cell cancers
(including lung) and melanoma. All
three patients ... to the effectiveness of JX-594 against liver cancers
including lung cancer," said Herbert M. Pinedo, ....
DAHANCA Initiates Head and Neck Cancer Study With Genmab's HuMax-EGFr
and acute and late side effects. About cancers
of the head and neck Head and neck cancers
may affect the mouth, nasal cavities, ... and lymphoma. Head and neck cancers
account for 3 % ...
International Journal of Occupational and Environmental Health Features Discovery of Asbestos-Related Pain Origin from Scientists at the Karmanos Cancer Institute in Detroit
... Cancer Institute's National Center for Vermiculite and Asbestos-Related cancers
(NCVAC) have discovered a probable reason for the unrelenting chest pain ... National Center for Vermiculite and Asbestos-Related cancers
(NCVAC at Karmanos)
In response to the United States ...
Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis
... Malignancies reported through week 104 consisted of two basal cell skin cancers
(one patient on SIMPONI 100 mg, one placebo patient). No deaths occurred. ... or other TNF blockers, your risk for developing lymphoma or other cancers
may increase. You should tell your doctor if you have had or develop ...
Enrollment in Delcath's Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy-Five Percent Accrual
... percutaneous hepatic perfusion (PHP(TM)) system for the treatment of cancers
of the liver, announced today that it has achieved the seventy-five ... in Phase III and Phase II clinical studies for the treatment of liver cancers
using high doses of melphalan. The Company's intellectual property ...
Heaviest Smokers Face Greatest Risk of Death After Lung Cancer Diagnosis
... who smoked two packs a day had a 58 percent higher risk of their lung cancers
returning or spreading compared with nonsmoking patients.
Smoking ... who smoked more than 61 packs a year had the greatest risk of their cancers
recurring, and their survival times were shortest. They were 41 percent ...
Entremed Presents Results of ENMD-2076 Phase 1 Study in Advanced Cancer Patients
... to expand this study and evaluate additional patients with a variety of cancers
as well as specifically those with colorectal and ovarian cancers. These ... of cancer. ENMD-2076 is currently in Phase 1 studies in advanced cancers
and multiple myeloma. The Company's other therapeutic candidates include ...
Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology
... more deaths from lung cancer alone than from breast, colon, and prostate cancers
combined - and it's extremely difficult to treat," said Professor Roy ... half of patients can survive for five years or more. However, few lung cancers
are found at this early stage and it is normally diagnosed at the advanced ...
Medarex Announces Preclinical Data from Multiple Research Programs Demonstrating Anti-Tumor Activity in Cancer
... in the CXC chemokine receptor family that is expressed on a variety of cancers
including leukemias, lymphomas, breast, lung, colon, pancreatic, and ... of the cell plasma membrane, that is expressed on most small cell lung cancers
(SCLC). In in vitro preclinical studies, a fully human, non-fucosylated ...
Karmanos Cancer Institute Researchers Present Breast Cancer Advancements at Conference
... before a novel experimental antitumor agent -- which works best in breast cancers
expressing the estrogen receptor (ER) -- estrogen receptors were ... agents and the drug combination," Dr. Burger said. "Triple-negative breast cancers
might respond against that drug (AFP464)."
Triple-negative breast ...
Genetic Source of Rare Childhood Cancer Found; Gene is Implicated in Other Cancers
... disease or certain other childhood cancers. In contrast, most pediatric cancers
occur sporadically, without any familial patterns. This led scientists and doctors to suspect that the cancers
were caused by an inherited genetic abnormality. To uncover the role of ...
Cylene to Present Advances in its Oral Inhibitor of CK2 at AACR Annual Meeting
... of protein kinase CK2. CK2 overexpression is well documented in many cancers
and represents a previously unexploited molecular target. CX-4945 is a ... in cancer cells. CX-4945, which has broad therapeutic potential in common cancers
as well as in niche indications, has advanced rapidly into Phase I ...
EAU Position Statement on Screening for Prostate Cancer
... well as the adverse
effects of overdiagnosis and overtreatment of prostate cancers
which could be
quantified for the first time in the setting of a ... due to a lack of
specificity and lack of selectivity for aggressive cancers
treatment. The development of novel diagnostic and ...
Landmark Study in The New England Journal of Medicine Shows HPV Testing Significantly Reduces Deaths from Cervical Cancer, Compared to other Methods Including Pap
... of HPV testing significantly reduces the numbers of advanced cervical cancers
and deaths, compared with Pap (cytology) testing or visual inspection with ... with a significant reduction in the numbers of advanced cervical cancers
and deaths from cervical cancer," QIAGEN's hc2 HPV testing platform "was ...
Ezetimibe and Ezetimibe/Simvastatin Combo Pose No Increased Cancer Risk, Study Shows
The Tufts researchers found 2,334 cases of cancers
reported in the total population studied. Cancer rates were analyzed ... continued Dr. Karas.
This research, which explored three times more cancers
than analyzed by Sir Richard Peto from the SEAS, SHARP and IMPROVE-IT ...
SGO and ACOG Announce Breast Cancer Fellowship Program for Gynecologic Oncologists
... who have received specialized training, and the link between gynecologic cancers
and breast cancers
is clear. We are extremely grateful to ACOG for recognizing this important ...
Dr. James F. Pingpank to Present at Leading Regional Therapies Conference
... Percutaneous Hepatic Perfusion ("PHP(TM)") System for the treatment of cancers
of the liver, announced today that Dr. James F. Pingpank will present at ... in Phase III and Phase II clinical studies for the treatment of liver cancers
using high doses of melphalan. The Company's intellectual property ...
Pivotal Data Published For First Biomarker Combination Test to Determine Risk of Ovarian Cancer in Women Who Present With Pelvic Mass
Ovarian cancer is the leading cause of death from gynecologic cancers
in the U.S. and the fifth-leading cause of cancer death in women. It accounts for 31% of cancers
of the female genital organs. There are an estimated 22,000 new cases ...